ONCOLOGY Flashcards Preview

CLINICAL CORRELATES IM PLAT > ONCOLOGY > Flashcards

Flashcards in ONCOLOGY Deck (108)
Loading flashcards...
1

ESOPHAGEAL CANCER RELATED TO SMOKING AND ALCOHOL, ARISING IN THE MIDDLE 1/3

SQUAMOUS CELL CARCINOMA

2

ESOPHAGEAL CANCER RELATED TO ACID REFLUX AND BARETT’S ESOPHAGUS ARISING IN TTHE DISTAL 1/3

ADENOCARCINOMA

3

INITIAL SYMPTOMS OF ESOPHAGEAL CANCER IN MAJORITY OF PATIENTS

ROGRESSIVE DYSPHAGIA AND WEIGHT LOSS

4

THRESHOLD OF DYSPHAGIA

>60% OF ESOPHAGEAL CIRCUMFERENCE IS INFILTRATED

5

TYPE OF GASTRIC ADENOCARCINOMA WITH LOSS OF CELL COHESION DEV3LOPING THROUGHOUT TH3 STOMACH RESULTING TO LOSS OF DISTENSIBITIY (LINITIS PLASTICA OR LEATHER BOTTLE APPEARANCE)

DIFFUSE TYPE

6

TYPE OF GASTRIC ADENOCARCINOMA FREQUENTLY ULCERATIVE AND INVOLVING THE ANTRUM AND LESSER CURVATURE

INTESTINAL TYPE

7

GASTRIC CANCER METASTATIC TO THE OVARY

KRUKENBERG TUMOR

8

GASTRIC CANCER METASTATIC TO HTE PERIUMBILICAL REGION

SISTER MARY JOSEPH NODES

9

GASTRIC CANCER METASTATIC TO THE SUPRACLAVICULAR LYMPH NODES

VIRCHOW NODES

10

MOST COMMON SITE FOR HEMATOGENOUS SPREAD OF GASTRIC CANCER

LIVER

11

ONLY CHANCE OF CURE FOR GASTRIC CANCER

COMPLETE SURGICAL REMOVAL OF TUMOR AND RESECTION OF ADJACENT LYMPH NODES

12

MOST FREQUENT SITE OF EXTRA-NODAL LYMPHOMA

STOMACH

13

PRIMARY TREATMENT OF GASTRIC MALT LYMPHOMA

ERADICATION OF H.PYLORI AS LONG IT HAS NOT TRANSFORMED INTO DLBCL

14

THREE DATES IN A WOMAN’S LIFE WITH MAJOR IMPACT OF BREAST CANCER RISK

AGE OF MENARCHE
FIRST FULL TERM PREGNANCY
AGE AT MENOPAUSE

15

BEST TIME FOR BREAST EXMAINATION

DAYS 5-6 OF MENSTRUAL CYCLE

16

MOST IMPORTANT PROGNOSTIC VARIABLE IN BREAST CANCER

TUMOR STAGE

17

HORMONAL TREATMENT FOR BREAT CANCER WHICH INCREASES THE RISK OF ENDOMETRIAL CANCER

SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERM)

18

TREATMENT THAT INCREASES BREAST CANCER RISK BUT DECREASES OVARIAN AND ENDOMETRIAL CANCER RISK

ORAL CONTRACEPTIVE PILLS

19

MONOCLONAL ANTIBODY DIRECTED AGAINST THE ERB/HER2-NEU RECEPTOR USED FOR BREAST CANCERS

TRASTUZUMAB

20

METHOD USED TO ASSESS HORMONAL AND HER-2 STATUS OF BREAST CARCINOMAS

IMMUNOHISTOCHEMISTRY (IHC) WITH ER, PR AND HER-2/NEU

21

USUALLY DONE IF IHC FOR HER-2 IS EQUIVOCAL TO ASCERTAIN HER-2 POSITIVITY

FISH

22

MAJORITY OF LUNG TUMORS ARE

CARCINOMAS

23

PRIMARY CAUSE OF LUNG CANCER WORLDWIDE

SMOKING

24

MOST COMMON HISTOLOGY OF LUNG CANCER OVERALL
MOST PREVALENT TYPE OF LUNG CANCER AMONG WOMEN
YOUND ADULTS AND NON-SMOKERS PRESENTING PERIPHERALLY

ADENOCARCINOMA OF THE LUNG

25

RESULTS FROM LOCAL EXTENSION OF TUMOR GROWING INN THE APEX INVOLVING C8 AND T1-T2 NERVE ROOTS WITH SHOULDER PAIN RADIATING TO THE ULNAR DISTRIBUTION AND HORNER’S SYNDROME

PANCOAST SYNDROME OR SUPERIOR SULCUS TUMOR

26

MOST COMMON LIFE THREATENING METABOLIC COMPLICATION OF MALIGNANCY ASSOCIATED WITH SQUAMOUS CELL CANCER OF THE LUNG

HYPERCALCEMIA FROM ECTOPIC PTH/PTH-RELATED PROTEIN PRODUCTION

27

PARANEOPLASTIC SYNDROMES ASSOCIATED WITH SMALL CELL LUNG CANCER

SIADH, CUSHING’S SYNDROME. LAMBERT EATON SYNDROME

28

TREATMENT OF CHOICE FOR EARLY (STAGE 1 OR 2) NON-SMALL CELL LUNG CANCER

SURGICAL RESECTION

29

TREATMENT OF CHOICE FOR SMALL CELL LUNG CANCER

CHEMOTHERAPY

30

MOST COMMON CANCER WORLDWIDE

LUNG CA